Search form

Latest News

Quidel Announces Preliminary Revenue for Fourth Quarter 2018

SAN DIEGO--(BUSINESS WIRE)--Jan. 7, 2019--
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a
provider of rapid diagnostic testing solutions, cellular-based virology
assays and molecular diagnostic systems, announced today that it expects
revenues in the fourth quarter of 2018 to be in the range of $132
million to $133 million

Read More »


Are you a determined, optimistic, team player? Quidel is looking for talented innovators who want to be part of revolutionizing medical diagnostics.

View Current Job Openings


To place orders, get assistance with shipments, pricing or contract administration view our Customer Support page.

Visit our Technical Support page to get help with product specifications, supporting docs or general support issues.

NEW: Register at to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments.